Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions

HMB45 is a mouse monoclonal antibody raised against Pmel17/gp100, a melanoma-specific marker, which is routinely used in the diagnosis of primary cutaneous malignant melanoma. The standard expression pattern for a positive HMB45 staining result on immunohistochemistry is based upon the results of ch...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rothberg, Bonnie E Gould, Moeder, Christopher B, Kluger, Harriet, Halaban, Ruth, Elder, David E, Murphy, George F, Lazar, Alexander, Prieto, Victor, Duncan, Lynn McDivitt, Rimm, David L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2570478/
https://ncbi.nlm.nih.gov/pubmed/18552823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2008.100
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak